Budget Impact Analysis Of Empagliflozin (Jardiance®) In Type-2 Diabetes Patients With High Cardiovascular Risk In The South African Setting- A Retrospective Claims Database Analysis
Abstract
Authors
J Carapinha R Carapinha G Doevendans J Cheynel